Emerging multifunctional aspects of cellular serine proteinase inhibitors in tumor progression and tissue regeneration (Q34592412)

3 August 2017

1 reference

title

Emerging multifunctional aspects of cellular serine proteinase inhibitors in tumor progression and tissue regeneration (English)

1 reference

3 August 2017

1 reference

Hiroaki Kataoka

1

1 reference

PubMed ID

11940213

3 August 2017

Hiroshi Itoh

series ordinal

2

1 reference

PubMed ID

11940213

3 August 2017

Masashi Koono

series ordinal

3

1 reference

3 August 2017

1 February 2002

1 reference

3 August 2017

Pathology International

1 reference

3 August 2017

52

1 reference

3 August 2017

2

1 reference

3 August 2017

89-102

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1827.2002.01320.X

3 August 2017

1 reference

An evaluation of the prognostic significance of alpha-1-antitrypsin expression in adenocarcinomas of the lung: an immunohistochemical analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1827.2002.01320.X

Tumor-associated proteases and inhibitors in gastric cancer: analysis of prognostic impact and individual risk protease patterns

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1827.2002.01320.X

Tumor-associated proteolysis and prognosis: new functional risk factors in gastric cancer defined by the urokinase-type plasminogen activator system

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1827.2002.01320.X

Enhanced tumor growth and invasiveness in vivo by a carboxyl-terminal fragment of alpha1-proteinase inhibitor generated by matrix metalloproteinases: a possible modulatory role in natural killer cytotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1827.2002.01320.X

Squamous cell carcinoma antigen is a new member of the serine protease inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1827.2002.01320.X

Establishment of a new human cancer cell line secreting protease nexin-II/amyloid beta protein precursor derived from squamous-cell carcinoma of lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1827.2002.01320.X

Reverse-zymographic analysis of protease nexin-II/amyloid beta protein precursor of human carcinoma cell lines, with special reference to the grade of differentiation and metastatic phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1827.2002.01320.X

Expression of trypsin in human cancer cell lines and cancer tissues and its tight binding to soluble form of Alzheimer amyloid precursor protein in culture.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1827.2002.01320.X

Purification and identification of a novel and four known serine proteinase inhibitors secreted by human glioblastoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1827.2002.01320.X

Increased secretory leukoprotease inhibitor in patients with nonsmall cell lung carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1827.2002.01320.X

Hepatocyte growth factor activator inhibitor, a novel Kunitz-type serine protease inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1827.2002.01320.X

Evaluation of hepatocyte growth factor activator inhibitor expression in normal and malignant colonic mucosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1827.2002.01320.X

Purification and cloning of hepatocyte growth factor activator inhibitor type 2, a Kunitz-type serine protease inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1827.2002.01320.X

Cloning of a new Kunitz-type protease inhibitor with a putative transmembrane domain overexpressed in pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1827.2002.01320.X

Cell-specific expression of alpha 1-antitrypsin in human intestinal epithelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1827.2002.01320.X

Properties of alpha 1-antitrypsin secreted by human adenocarcinoma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1827.2002.01320.X

The serpin-enzyme complex (SEC) receptor mediates the neutrophil chemotactic effect of alpha-1 antitrypsin-elastase complexes and amyloid-beta peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1827.2002.01320.X

beta-Amyloid peptide, substance P, and SEC receptor ligand activate cytoplasmic Ca2+ in neutrophil-like HL-60 cells: effect of chemotactic peptide antagonist BocMLF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1827.2002.01320.X

Human monocyte activation by cleaved form of alpha-1-antitrypsin involvement of the phagocytic pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1827.2002.01320.X

Correlation between spontaneous metastatic potential and type I collagenolytic activity in a human pancreatic cancer cell line (SUIT-2) and sublines

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1827.2002.01320.X

Changing views of the role of matrix metalloproteinases in metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1827.2002.01320.X

Matrix metalloproteinases. Matrix degradation and more

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1827.2002.01320.X

Interstitial collagenase (matrix metalloproteinase-1) expresses serpinase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1827.2002.01320.X

The serpin alpha1-proteinase inhibitor is a critical substrate for gelatinase B/MMP-9 in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1827.2002.01320.X

Apparent tumour specificity with the SCM test

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1827.2002.01320.X

Identification of a serpin-enzyme complex receptor on human hepatoma cells and human monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1827.2002.01320.X

The SEC receptor: a possible link between neonatal hepatitis in alpha 1-antitrypsin deficiency and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1827.2002.01320.X

α1-Antitrypsin is an effector of immunological stasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1827.2002.01320.X

Fucosylated forms of alpha-1-antitrypsin that predict unresponsiveness to chemotherapy in ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1827.2002.01320.X

alpha 1-Proteinase inhibitor, alpha 1-antichymotrypsin, and alpha 2-macroglobulin are the antiapoptotic factors of vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1827.2002.01320.X

Co-expression of urokinase, urokinase receptor and PAI-1 is necessary for optimum invasiveness of cultured lung cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1827.2002.01320.X

Absence of host plasminogen activator inhibitor 1 prevents cancer invasion and vascularization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1827.2002.01320.X

The serpin PAI-1 inhibits cell migration by blocking integrin alpha V beta 3 binding to vitronectin

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1827.2002.01320.X

The plasminogen activator inhibitor PAI-1 controls in vivo tumor vascularization by interaction with proteases, not vitronectin. Implications for antiangiogenic strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1827.2002.01320.X

Inhibition of apoptosis in human tumour cells by the tumour-associated serpin, SCC antigen-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1827.2002.01320.X

Secreted form of amyloid beta protein precursor is involved in the growth regulation of fibroblasts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1827.2002.01320.X

From differentiation to proliferation: the secretory amyloid precursor protein as a local mediator of growth in thyroid epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1827.2002.01320.X

A possible role for the Alzheimer amyloid precursor protein in the regulation of epidermal basal cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1827.2002.01320.X

beta-Amyloid precursor protein binds to the neurite-promoting IKVAV site of laminin

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1827.2002.01320.X

Coagulation factor XIa cleaves the RHDS sequence and abolishes the cell adhesive properties of the amyloid beta-protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1827.2002.01320.X

Down-regulation of the amyloid protein precursor of Alzheimer's disease by antisense oligonucleotides reduces neuronal adhesion to specific substrata.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1827.2002.01320.X

Wild-type but not Alzheimer-mutant amyloid precursor protein confers resistance against p53-mediated apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1827.2002.01320.X

The Alzheimer amyloid precursor protein (APP) and FE65, an APP-binding protein, regulate cell movement

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1827.2002.01320.X

beta-Amyloid precursor protein-deficient mice show reactive gliosis and decreased locomotor activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1827.2002.01320.X

Generation of APLP2 KO mice and early postnatal lethality in APLP2/APP double KO mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1827.2002.01320.X

Amino acid sequence RERMS represents the active domain of amyloid beta/A4 protein precursor that promotes fibroblast growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1827.2002.01320.X

Secreted beta-amyloid precursor protein stimulates mitogen-activated protein kinase and enhances tau phosphorylation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1827.2002.01320.X

Phosphorylation of mitogen-activated protein kinase is altered in neuroectodermal cells overexpressing the human amyloid precursor protein 751 isoform

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1827.2002.01320.X

Hepatocyte growth factor: a multifunctional cytokine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1827.2002.01320.X

Hepatocyte growth factor (HGF) as a tissue organizer for organogenesis and regeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1827.2002.01320.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1827.2002.01320.X

A novel protease obtained from FBS-containing culture supernatant, that processes single chain form hepatocyte growth factor to two chain form in serum-free culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1827.2002.01320.X

Activation of hepatocyte growth factor in the injured tissues is mediated by hepatocyte growth factor activator.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1827.2002.01320.X

Hepatocyte growth factor activator: a possible regulator of morphogenesis during fetal development of the rat gastrointestinal tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1827.2002.01320.X

Activation of hepatocyte growth factor (HGF) by endogenous HGF activator is required for metanephric kidney morphogenesis in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1827.2002.01320.X

Genomic structure and chromosomal localization of the human hepatocyte growth factor activator inhibitor type 1 and 2 genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1827.2002.01320.X

Mouse hepatocyte growth factor activator inhibitor type 1 (HAI-1) and type 2 (HAI-2)/placental bikunin genes and their promoters

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1827.2002.01320.X

Hepatocyte growth factor activator inhibitor type 1 is a specific cell surface binding protein of hepatocyte growth factor activator (HGFA) and regulates HGFA activity in the pericellular microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1827.2002.01320.X

Distribution of hepatocyte growth factor activator inhibitor type 1 (HAI-1) in human tissues. Cellular surface localization of HAI-1 in simple columnar epithelium and its modulated expression in injured and regenerative tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1827.2002.01320.X

Matriptase and HAI-1 are expressed by normal and malignant epithelial cells in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1827.2002.01320.X

Multiple sites of proteolytic cleavage to release soluble forms of hepatocyte growth factor activator inhibitor type 1 from a transmembrane form

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1827.2002.01320.X

Purification and characterization of a complex containing matriptase and a Kunitz-type serine protease inhibitor from human milk

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1827.2002.01320.X

Cellular localization of membrane-type serine protease 1 and identification of protease-activated receptor-2 and single-chain urokinase-type plasminogen activator as substrates

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1827.2002.01320.X

Characterization of placental bikunin, a novel human serine protease inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1827.2002.01320.X

Expression profiling of gastric adenocarcinoma using cDNA array

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1827.2002.01320.X

Functional analysis of secreted and transmembrane proteins critical to mouse development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1827.2002.01320.X

Isolation, properties, and complete amino acid sequence of human secretory leukocyte protease inhibitor, a potent inhibitor of leukocyte elastase

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1827.2002.01320.X

Secretory leukocyte protease inhibitor: a human saliva protein exhibiting anti-human immunodeficiency virus 1 activity in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1827.2002.01320.X

Secretory leukocyte protease inhibitor mediates non-redundant functions necessary for normal wound healing

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1827.2002.01320.X

Inhibition of NF-kappaB activation and augmentation of IkappaBbeta by secretory leukocyte protease inhibitor during lung inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1827.2002.01320.X

Identification and cloning of a novel isoform of mouse secretory leukocyte protease inhibitor, mSLPI-beta, overexpressed in murine leukemias and a highly liver metastatic tumor, IMC-HA1 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1827.2002.01320.X

Tissue factor pathway inhibitor-2 is a novel inhibitor of matrix metalloproteinases with implications for atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1827.2002.01320.X

Tumor cell adhesion and migration supported by interaction of a receptor-protease complex with its inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1827.2002.01320.X

Role of tissue factor pathway inhibitor-2 (TFPI-2) in amelanotic melanoma (C-32) invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1827.2002.01320.X

Paradoxical pro-invasive effect of the serine proteinase inhibitor tissue factor pathway inhibitor-2 on human hepatocellular carcinoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1827.2002.01320.X

Proteolytic inactivation of human α1 antitrypsin by human stromelysin

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1827.2002.01320.X

10.1046/J.1440-1827.2002.01320.X

21 January 2018

Identifiers

DOI

1 reference

3 August 2017

1 reference

PubMed ID

11940213